Sanigen KRX:188260KOSDAQ
세니젠 · Korean news coverage and regulatory filings, organized.
In Q3 2026, Sanigen reported revenue of ₩4.2bn, up 3.8% year on year, and an operating loss of ₩438m. Sanigen (세니젠) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals 4 quarters of losses Screener
Sanigen today: up or down?
No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.
Upcoming dates as filed
- Mar 31 Annual report filing deadlinein 135 days · period ending Dec 2026
Dates Sanigen stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.
Sanigen quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q3 2026 | ₩4.2bn | +3.8% | −₩438m margin −10.4% | −₩682m |
| Q2 2026 | ₩3.8bn | -55.5% | −₩405m margin −10.6% | −₩145m |
| Q1 2026 | ₩3.3bn | -56.9% | −₩872m margin −26.3% | −₩898m |
| Q4 2025 derived check units | −₩4.9bn | – | −₩1.8bn | −₩3.2bn |
| Q3 2025 | ₩4.1bn | -38.5% | −₩908m margin −22.4% | −₩937m |
| Q2 2025 | ₩8.6bn | +50.8% | −₩791m margin −9.2% | −₩812m |
| Q1 2025 | ₩7.7bn | +62.2% | −₩891m margin −11.6% | −₩904m |
| Q4 2024 derived check units | −₩1.6bn | – | −₩1.8bn | −₩2.5bn |
Sanigen ranks #1610 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Sanigen top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.